Executive Interview – Abzena plc

Executive Interview – Abzena plc

Abzena [AIM:ABZA] is a UK group, which offers a range of key services and technologies that enable its customers to develop safer and more effective biological products. The company consists of three main operating business units: Antitope (immunogenicity testing, protein engineering, cell line development), PolyTherics (bioconjugation, polymer/synthetic chemistry) and the recently acquired PacificGMP (biomanufacturing).


You may also be interested in these:

Consumer

BAT – H125 results highlights

Healthcare

Oryzon Genomics – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free